185 related articles for article (PubMed ID: 30033503)
1. Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis.
Ahmed M; Ul Haq I; Faisal M; Waseem D; Taqi MM
J Mol Neurosci; 2018 Aug; 65(4):472-479. PubMed ID: 30033503
[TBL] [Abstract][Full Text] [Related]
2. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
Kumar D; Chakraborty J; Das S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
[TBL] [Abstract][Full Text] [Related]
3. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
4. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
5. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
Kapur S; Sharad S; Singh RA; Gupta AK
J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
[TBL] [Abstract][Full Text] [Related]
6. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
7. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.
Xu J; Lu Z; Xu M; Pan L; Deng Y; Xie X; Liu H; Ding S; Hurd YL; Pasternak GW; Klein RJ; Cartegni L; Zhou W; Pan YX
J Neurosci; 2014 Aug; 34(33):11048-66. PubMed ID: 25122903
[TBL] [Abstract][Full Text] [Related]
8. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function.
Mague SD; Port RG; McMullen ME; Carlson GC; Turner JR
Neuropharmacology; 2015 Oct; 97():426-35. PubMed ID: 25986698
[TBL] [Abstract][Full Text] [Related]
9. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
[TBL] [Abstract][Full Text] [Related]
10. Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons.
Halikere A; Popova D; Scarnati MS; Hamod A; Swerdel MR; Moore JC; Tischfield JA; Hart RP; Pang ZP
Mol Psychiatry; 2020 Jul; 25(7):1406-1419. PubMed ID: 31481756
[TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
[TBL] [Abstract][Full Text] [Related]
12. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.
Tolami HF; Sharafshah A; Tolami LF; Keshavarz P
J Mol Neurosci; 2020 Apr; 70(4):504-513. PubMed ID: 31853823
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
14. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.
Zhang Y; Wang D; Johnson AD; Papp AC; Sadée W
J Biol Chem; 2005 Sep; 280(38):32618-24. PubMed ID: 16046395
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
16. A118G mu opioid receptor polymorphism among drug addicts in Malaysia.
Nagaya D; Ramanathan S; Ravichandran M; Navaratnam V
J Integr Neurosci; 2012 Mar; 11(1):117-22. PubMed ID: 22744787
[TBL] [Abstract][Full Text] [Related]
17. Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.
Zhang Y; Picetti R; Butelman ER; Ho A; Blendy JA; Kreek MJ
Neuropsychopharmacology; 2015 Mar; 40(5):1091-100. PubMed ID: 25336208
[TBL] [Abstract][Full Text] [Related]
18. Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat.
Briand LA; Hilario M; Dow HC; Brodkin ES; Blendy JA; Berton O
J Neurosci; 2015 Feb; 35(8):3582-90. PubMed ID: 25716856
[TBL] [Abstract][Full Text] [Related]
19. Neurobehavioral effects of neonatal opioid exposure in mice: Influence of the OPRM1 SNP.
Robinson SA; Jones AD; Brynildsen JK; Ehrlich ME; Blendy JA
Addict Biol; 2020 Sep; 25(5):e12806. PubMed ID: 31267641
[TBL] [Abstract][Full Text] [Related]
20. Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.
Popova D; Desai N; Blendy JA; Pang ZP
J Neurosci; 2019 Jul; 39(29):5685-5696. PubMed ID: 31109961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
